代谢与葡萄糖健康
Metabolic & Glucose Health
平衡身体的葡萄糖水平，从消化吸收到细胞能量利用。
Supporting balanced glucose levels from digestion and absorption through to cellular energy utilisation.
在产品页展开Explore on ProductsPRECISION HEALTH INNOVATION
以科学洞察人体以精准定义产品
Understanding Health
Through Science
创立于澳大利亚，专注药品开发、营养科学、活性成分与制剂技术。我们关注身体自身修复能力，而非对伪健康指标进行强行干预。
Founded in Australia, we focus on pharmaceutical development, nutritional science, bioactives and formulation technology. We support the body’s own capacity for repair rather than forcing change in superficial markers of health.
RESEARCH AREAS
我们关注的问题
Where We Focus
持续深耕五个精准研究领域，它们与生活幸福息息相关。
We continue to advance five precision research areas closely connected to everyday health and quality of life.
饮酒状态管理
Alcohol-Related Wellbeing
拆解酒精的吸收、代谢，身体营养状态与次日感受之间的连续过程。以最小代价提升主观感受和减小身体负担。
Examining the continuum between alcohol absorption and metabolism, nutritional status and next-day wellbeing—seeking a better experience with less burden on the body.
在产品页展开Explore on Products
胃肠健康
Gastrointestinal Health
研究胃肠环境、营养递送与功能材料。保护亚健康饮食习惯下的肠道功能和微环境平衡。
Researching gastrointestinal conditions, nutrient delivery and functional materials to support gut function and microenvironmental balance under less-than-ideal dietary habits.
在产品页展开Explore on Products
健康老龄化
Healthy Ageing
关注常用“减龄”方式给身体带来的额外损伤，做维护持续健康而非表面健康的产品。
Examining the added physiological burden of common age-defying approaches to create products that support lasting health—not merely its appearance.
在产品页展开Explore on Products
肝脏健康
Liver Health
关注如何辅助提高肝脏自修复能力，而非干预肝脏外部指标变化。
Exploring how to support the liver’s intrinsic repair capacity rather than focusing solely on externally measured indicators.
在产品页展开Explore on ProductsSCIENCE & INNOVATION
从具体问题出发
把科学落实到产品
From a Specific Problem
to a Science-Led Product
研发沿一条连续路径推进：先定义人体问题，再判断证据是否适用于最终产品；随后以配方与工艺把科学转化为可生产、可验证的产品。
Development follows one continuous path: define the human problem, judge whether the evidence applies to the finished product, then use formulation and process design to create something manufacturable and verifiable.
定义具体人体问题
Define the Human Problem
理解人体真正发生了什么，明确目标人群、使用场景与支持边界。
Understand what is happening, then define the target user, use context and product boundaries.
从临床证据到原料可比性
From Clinical Evidence to Material Comparability
确认研究结论、研究剂量与研究原料能否真实进入最终产品。
Determine whether research findings, study doses and materials genuinely apply to the finished product.
配方本身就是科学的一部分
Formulation Is Part of the Science
用剂型、工艺与材料减法提升表现，而不是依赖堆料或超剂量。
Use dosage form, process design and material reduction—not ingredient loading or excessive dosing—to improve performance.
验证能否生产与放行
Verify Manufacture and Release
以规格、分析、稳定性和法规要求，确认设计能否成为稳定产品。
Use specifications, analysis, stability and regulatory requirements to confirm a reliable product.
QUALITY & REGULATORY
质量与合规
支撑全球市场准入
Quality & Compliance
for Global Market Access
取得全球多个国家的处方药、非处方药和功能性食品准入，并将产品分类、证据、生产质量、标签及上市后要求纳入开发流程。
Market access has been obtained across multiple countries for prescription medicines, over-the-counter medicines and functional foods, supported by integrated classification, evidence, manufacturing quality, labelling and post-market requirements.
01分类与准入路径Classification & Access处方药 · 非处方药 · 功能性食品Prescription · OTC · Functional Foods
02原料与批次控制Materials & Batches身份 · 含量 · 污染物 · 一致性Identity · Assay · Contaminants · Consistency
03稳定性与上市维护Stability & Lifecycle货架期 · 标签 · 变更 · 上市后管理Shelf Life · Labelling · Change · Oversight
查看市场准入与质量体系Explore market access and quality↗
GLOBAL RESEARCH NETWORK
汇聚全球高校资源
Connecting Global Academic Expertise
以澳大利亚为中心，连接药品科学、营养研究、临床转化与原料评价能力，让不同学科围绕同一具体问题协同推进。
Centred in Australia, the network connects pharmaceutical science, nutrition, clinical translation and ingredient evaluation around specific health questions.
蒙纳士大学MONASH UNIVERSITY药品科学与机制Pharmaceutical Science & Mechanisms新加坡国立大学NATIONAL UNIVERSITY OF SINGAPORE营养科学与研究设计Nutrition Science & Study Design柏林夏里特医学院CHARITÉ BERLIN临床与转化研究Clinical & Translational Research加州大学戴维斯分校UC DAVIS食品、营养与原料评价Food, Nutrition & Ingredients
机构名称仅说明相关人员或实验室的学术隶属关系。Institution names identify academic affiliation and do not imply endorsement.查看公司与全球研究网络Explore the company and research network↗SCIENCE & INNOVATION
从具体问题到可验证产品
From Problem to Verifiable Product
我们的研发不从成分清单开始，而从一个具体人体问题开始；随后依次完成证据判断、配方设计与成品验证。
Our development process does not begin with an ingredient list. It begins with a specific human problem, then moves through evidence, formulation and finished-product verification.
FROM PROBLEM TO PRODUCT
一条连续路径
四个关键判断
One Path. Four Critical Judgements.
每一阶段只回答一个核心问题，上一阶段的结论成为下一阶段的输入。科学不是附加在产品上的说明，而是贯穿研发全过程的决策依据。
Each stage answers one core question, and its conclusion becomes the input for the next. Science is not an explanation added after the fact; it guides every development decision.
问题PROBLEM
定义研究起点DEFINE THE STARTING POINT
人体真正发生了什么？
What Is Actually Happening?
从目标人群和真实使用场景出发，梳理消化吸收、代谢信号、组织利用和主观感受之间的连续关系；把宽泛需求收敛为明确的支持目标、评价指标与产品边界。
Start with the target user and real use context. Map the relationship between digestion, metabolic signalling, tissue utilisation and perceived wellbeing, then turn a broad need into a defined target, outcome and product boundary.
目标人群Target User谁正在面对这个问题Who experiences the problem
真实场景Real Context问题在何时、何种条件下发生When and under what conditions it occurs
支持边界Support Boundary产品应该做什么，也明确不做什么What the product should—and should not—support
证据EVIDENCE
判断研究能否进入产品JUDGE PRODUCT RELEVANCE
从临床证据到原料可比性
From Clinical Evidence to Material Comparability
研究存在，不等于能够直接支持最终产品。我们依次检查人体研究的人群与终点、不同研究结果的一致性、作用机制的合理性，以及研究原料在来源、工艺、活性指标和剂量上与最终产品的可比性。
The existence of research does not mean it directly supports the finished product. We examine study populations and endpoints, consistency across studies, biological plausibility and whether the studied material is comparable in source, process, active markers and dose.
人体研究Human Studies人群、设计、终点与结果Population, design, endpoints and outcomes
证据一致性Consistency比较多项研究的方向与质量Direction and quality across studies
机制合理性Plausibility是否符合目标功能与使用场景Fit with the intended function and context
原料可比性Comparability来源、工艺、指标与剂量Source, process, markers and dose
配方FORMULATION
把证据转化为产品设计TURN EVIDENCE INTO DESIGN
配方本身就是科学的一部分
Formulation Is Part of the Science
材料进入配方后，颗粒大小、溶解与分散、相容性、胃肠环境、剂型、加工参数和包装都会改变产品表现。我们用原型测试与工艺替代做材料减法，避免以堆料或超剂量制造伪功效。
Once materials enter a formulation, particle size, dissolution, dispersion, compatibility, gastrointestinal conditions, dosage form, processing and packaging can all change performance. Prototype testing and process alternatives help remove unnecessary materials and avoid ingredient loading or excessive dosing.
材料表现Material Performance粒径、溶解、分散与相容性Particle size, dissolution, dispersion and compatibility
剂型与工艺Dosage Form & Process包埋、释放、加工与包装保护Encapsulation, release, processing and package protection
设计减法Design Reduction删减不必要材料与过量剂量Remove unnecessary materials and excessive dose
验证VERIFY
确认设计能够稳定落地CONFIRM THE DESIGN CAN BE DELIVERED
能否成为可生产、可放行的产品？
Can It Become a Manufacturable, Releasable Product?
最终以成品规格、分析方法、批次一致性、加速与长期稳定性、包装适配性及目标市场法规要求，验证设计是否能够稳定生产、准确说明并持续放行。
Finished-product specifications, analytical methods, batch consistency, accelerated and long-term stability, packaging compatibility and market rules confirm whether the design can be manufactured reliably, described accurately and released consistently.
质量规格Specifications身份、含量、污染物与性能指标Identity, assay, contaminants and performance
稳定性与包装Stability & Packaging关键属性、保护能力与货架期Critical attributes, protection and shelf life
法规与放行Regulatory & Release分类、标签、生产记录与批次结果Classification, labelling, records and batch results
我们的判断标准OUR STANDARD
科学，不在于加入更多
Science Is Not About Adding More
选择有依据Every Choice Has a Reason
材料有必要Every Material Is Necessary
要求能验证Every Requirement Is Verifiable
FIVE RESEARCH AREAS · FLAGSHIP PRODUCTSFIVE RESEARCH AREAS
代表性产品，与你的幸福息息相关
Products for Better Living
我们的五个研究领域，源于日常生活中真实而具体的需要：保持更稳定的状态、吃得更安心、从容面对年龄变化，也减轻忙碌生活给身体带来的负担。每一款代表性产品，都希望把严谨的科学转化为对生活真正有帮助的选择。
Five research areas address real everyday needs. Each product turns focused science into practical support for healthier living.
注：最终市场产品包装会根据当地法规调整。Note: Final market packaging may be adjusted to meet local regulatory requirements.
PRODUCTS & RESEARCH AREAS
五个研究领域的
代表性产品
Flagship Products Across
Five Research Areas
每个研究领域都对应一种真实的健康需要，并形成目标清晰、适用人群明确、设计逻辑独立的代表性产品。
Each research area responds to a real health need through a flagship product with a clear purpose, defined audience and distinct design logic.
FLAGSHIP PRODUCT
METABOLIC & GLUCOSE HEALTHMeta-Glu Conductor
Meta-Glu Conductor
解决什么问题？
What Problem Does It Address?
谁需要它？
Who Is It For?
有何优势？
What Makes It Different?
QUALITY & REGULATORY
质量始于设计
Quality
Begins by Design
覆盖处方药、非处方药与功能性食品的质量体系，从产品分类、证据与生产放行延伸至上市后管理，让每一项要求都可追溯、可复核、可验证。
Our quality system spans prescription medicines, OTC medicines and functional foods—from classification, evidence and batch release to post-market oversight—so every requirement remains traceable, reviewable and verifiable.
AUSTRALIAN REGULATORY DISCIPLINE
以严格监管纪律
管理适用产品
Managing Applicable Products
with Regulatory Discipline
Non Stop Health Tech Australia Pty Ltd 将产品分类、允许成分、证据、生产质量、标签、广告和上市后义务纳入开发计划，并按每项产品的法律分类与登记路径准确表述监管状态。
Non Stop Health Tech Australia Pty Ltd integrates classification, permitted ingredients, evidence, manufacturing quality, labelling, advertising and post-market obligations into development planning, with regulatory status described according to each product's legal pathway.
可信赖，来自可追溯的判断、记录与放行TRUST IS BUILT THROUGH TRACEABLE DECISIONS, RECORDS AND RELEASE
从准入判断到批次记录，每一步都需要清晰责任、适用标准与可复核证据。
From market-access decisions to batch records, each step requires clear responsibility, applicable criteria and reviewable evidence.
FROM ACCESS TO LIFECYCLE
从市场准入到全生命周期质量
From Market Access to Lifecycle Quality
先判断产品分类，再根据风险、证据与目标市场要求建立适用的控制组合。
Classification comes first; controls then follow product risk, evidence and target-market requirements.
处方药Prescription Medicines分类 · 证据CLASSIFICATION · EVIDENCE明确适用范围、临床证据与处方监管责任Defined scope, clinical evidence and prescribing accountability非处方药OTC Medicines宣称 · 标签CLAIMS · LABELLING统一功能边界、消费者标签与广告要求Aligned claim boundaries, consumer labelling and advertising功能性食品Functional Foods成分 · 食品法规INGREDIENTS · FOOD RULES核对允许成分、功能声称与食品法规路径Permitted ingredients, health claims and food-law pathways不同分类，同一套可追溯的质量生命周期DIFFERENT CATEGORIES · ONE TRACEABLE QUALITY LIFECYCLE
原材料
Raw Materials
评估供应商与原料身份，控制标志物、含量、微生物、重金属及其他风险指标，确认批次一致性。
Assess suppliers and material identity; control markers, assay, microbiology, heavy metals and other risks; confirm batch consistency.
配方
Formulation
确认剂量、相容性、剂型与辅料，并把粒径、崩解、溶解、分散等表现纳入设计。
Confirm dose, compatibility, dosage form and excipients, while designing for particle size, disintegration, dissolution and dispersion.
生产
Manufacturing
由合格生产商执行工艺控制、过程检测与偏差管理，使实验室设计稳定转入批量生产。
Qualified manufacturers apply process controls, in-process testing and deviation management so laboratory design transfers reliably to scale.
分析检测
Analytical Testing
以适用方法测量身份、含量或标志物、污染物和物理性能，为批次放行提供客观依据。
Measure identity, assay or markers, contaminants and physical performance with suitable methods to support objective batch release.
稳定性
Stability
结合加速与长期数据评估关键指标、包装保护能力和货架期，并持续跟踪上市后表现。
Use accelerated and real-time data to evaluate critical attributes, packaging protection and shelf life, then continue post-market monitoring.
法规管理
Regulatory
持续管理分类、允许成分、证据、标签、广告和变更记录，使产品始终符合目标市场要求。
Maintain classification, permitted ingredients, evidence, labelling, advertising and change records against target-market requirements.
QUALITY GATES
每个关键节点
都需要明确的放行依据
Defined Release Criteria
at Every Critical Gate
项目只有在分类、原料、配方、生产和证据要求达到预设标准后，才进入下一阶段。
A programme moves forward only when classification, materials, formulation, manufacturing and evidence requirements meet defined criteria.
产品定义
Product Definition
确认产品分类、目标市场、目标人群、使用场景、预期功能与宣称边界，形成清晰的开发起点。
Confirm classification, market, target user, use context, intended function and claim boundaries before development begins.
原料准入
Material Qualification
复核供应商资质、身份鉴别、规格、活性指标、污染物及目标市场法规适用性。
Review suppliers, identity, specifications, active markers, contaminants and regulatory suitability.
配方确认
Formulation Confirmation
确认剂量、相容性、剂型、辅料与关键工艺参数，使实验室原型能够稳定转入生产。
Confirm dose, compatibility, dosage form, excipients and process parameters so the prototype can transfer into production.
批次放行
Batch Release
核对生产记录、过程检测、成品规格、偏差处理与放行结果，保证批次符合预设标准。
Review production records, in-process testing, specifications, deviations and release results against defined standards.
持续维护
Lifecycle Maintenance
持续观察稳定性、投诉趋势、供应商表现和法规变化，并在任何变更前完成风险评估。
Monitor stability, complaints, supplier performance and regulatory change, with risk assessment before any change.
POST-MARKET OVERSIGHT
上市不是质量管理的终点
Quality Continues After Market Entry
产品上市后仍需通过信息收集、趋势分析与受控变更，维持产品与既定标准的一致性。
After market entry, information collection, trend analysis and controlled change help maintain alignment with established standards.
投诉与反馈复核Complaint Review
对产品质量、包装、使用体验及潜在安全信息进行分类，持续观察是否出现重复或上升趋势。
Classify product quality, packaging, use-experience and potential safety information, then monitor recurring or rising trends.
变更控制Change Control
在原料、供应商、工艺、包装或标签发生变化前，评估影响、确认责任并形成完整记录。
Assess impact, ownership and documentation before changes to materials, suppliers, process, packaging or labelling.
持续稳定性Ongoing Stability
按照适用的稳定性计划持续观察关键质量属性、包装保护能力与货架期表现。
Continue to monitor critical quality attributes, packaging protection and shelf-life performance through stability programmes.
法规动态跟踪Regulatory Watch
跟踪目标市场对成分、宣称、警示语、标签及广告要求的变化，并及时评估产品影响。
Monitor changes to ingredient, claim, warning, labelling and advertising rules and assess their product impact.
ABOUT NON STOP
二十五年持续探索精准健康
Twenty-Five Years
of Precision Health
创立于澳大利亚。二十五年来，我们持续连接药品开发、营养科学、活性成分研究与制剂技术，以科学、质量与法规经验推动更精准的健康产品。
Founded in Australia. For twenty-five years, we have connected medicine development, nutritional science, bioactive research and formulation technology to create more precise health products grounded in science, quality and regulatory discipline.
OUR JOURNEY
持续演进的研发视野
An Evolving Development Perspective
2001创立于澳大利亚Founded in Australia从药品与健康产品相关领域起步，建立以科学、质量和法规为基础的开发视角。Began in medicine and health products with a development perspective grounded in science, quality and regulation.
2000年代2000s药品与法规经验Medicines & Regulatory逐步积累处方药、非处方药、质量体系与多市场法规管理经验。Built experience across prescription medicines, OTC products, quality systems and multi-market regulation.
2010年代2010s产品走向全球市场Global Product Reach代表性产品曾进入 80+ 国家市场，并将开发方法延伸至消费者健康与营养科学。A flagship product reached more than 80 countries as development methods expanded into consumer health and nutritional science.
现在Today聚焦精准健康Precision Health持续深耕五个健康研究领域，把机制、证据、制剂与质量连接到精准产品设计。Focused on five research areas, connecting physiology, evidence, formulation and quality to more precise product design.
CONNECTED BY SCIENCE
以澳大利亚为中心
连接全球高校资源
Academic Connections
Centred in Australia
相关研究活动曾涉及来自蒙纳士大学、新加坡国立大学、柏林夏里特医学院及加州大学戴维斯分校的研究人员或相关实验室。不同节点分别补充药品科学、营养研究、临床转化与原料评价能力。
Research connections across Monash University, NUS, Charité Berlin and UC Davis bring together expertise in pharmaceutical science, nutrition, clinical translation and ingredient evaluation.
AU蒙纳士大学Monash University墨尔本 · 药品科学与机制研究Melbourne · Pharmaceutical science and mechanisms
为人体机制、药品科学与功能材料评价提供跨学科研究视角。
Contributes cross-disciplinary perspectives on human mechanisms, pharmaceutical science and functional-material evaluation.
SG新加坡国立大学National University of Singapore新加坡 · 营养科学与研究设计Singapore · Nutritional science and study design
补充亚洲人群、营养科学与研究设计方面的研究视角。
Adds research perspectives on Asian populations, nutritional science and study design.
DE柏林夏里特医学院Charité – Universitätsmedizin Berlin柏林 · 临床医学与转化研究Berlin · Clinical and translational research
连接临床问题、作用机制与证据路径，推动研究向实际健康需求转化。
Connects clinical questions, mechanisms and evidence pathways to real health needs.
US加州大学戴维斯分校University of California, Davis加州 · 食品、营养与原料研究California · Food, nutrition and ingredient research
补充食品科学、营养研究、功能性原料与产品评价方面的专业视角。
Adds expertise in food science, nutrition, functional ingredients and product evaluation.
药品科学与机制Pharmaceutical science & mechanisms营养科学与研究设计Nutrition & study design临床与转化研究Clinical & translational食品、营养与原料评价Food, nutrition & ingredients
机构名称用于说明相关人员或实验室的学术隶属关系，不代表机构对产品作出背书。Institution names identify academic affiliation and do not imply institutional endorsement of products.
GLOBAL MARKET EXPERIENCE
从产品开发
走向多市场准入
From Product Development
to Multi-Market Access
自 2001 年以来，我们持续积累处方药、非处方药与功能性食品的开发及法规经验，代表性产品曾覆盖 80+ 国家与地区。这套经验让证据、质量、标签与市场准入从产品定义之初便进入同一条开发路径。
Since 2001, we have built development and regulatory experience across prescription medicines, OTC medicines and functional foods, with a flagship product reaching more than 80 countries and regions. Evidence, quality, labelling and market access are considered together from the moment a product is defined.
80+代表性产品覆盖国家与地区Countries and regions reached
25+年健康产品开发经验Years of health-product experience
30+产品开发与多市场准入项目Development and market-access programmes
5+持续推进的精准健康研究领域Precision-health research areas in progress
亚太市场
Asia Pacific
业务经验覆盖澳大利亚、香港、新加坡及其他东南亚市场，整合产品分类、允许成分、剂量、证据、本地化标签以及进口与销售要求。
Experience across Australia, Hong Kong, Singapore and other Southeast Asian markets integrates classification, permitted ingredients, dose, evidence, local labelling, import and distribution requirements.
欧洲市场
Europe
面向德国及其他欧洲市场，衔接药品、食品补充剂或功能性食品分类，以及原料规格、生产质量、健康声称和多语言标签要求。
Across Germany and other European markets, development connects medicine, food-supplement or functional-food classification with material specifications, manufacturing quality, claims and multilingual labels.
美洲市场
Americas
面向美国及其他美洲市场，围绕膳食补充剂、食品或药品分类，建立可追溯的原料资料、产品规格、标签文本与供应链质量文件。
Across the United States and other American markets, programmes build traceable ingredient files, specifications, labelling and supply-chain quality documentation around supplement, food or medicine classification.
其他主要地区
Other Major Regions
在中东、非洲及其他增长市场，将当地代理、产品分类、注册资料、自由销售或生产质量证明，以及本地语言和渠道要求纳入同一准入体系。
Across the Middle East, Africa and other growth markets, local representation, classification, registration dossiers, sale or manufacturing certificates, language and channel requirements enter one access framework.
科学持续向前，我们亦然
SCIENCE CONTINUES. SO DO WE.